Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Starpharma Pty Ltd
With
National Institute of Allergy and Infectious Diseases (NIAID)
Age
18–any
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Provision of written informed consent
Healthy males aged 18 years or older
HIV negative
Reports vaginal intercourse in the past 12 months
Agrees to abstain from vaginal, anal (receptive and insertive) and oral sexual intercourse, and agrees to refrain from masturbation during the 7 days of product use until after the End-of-Treatment (Day 7) study visit
You may not be if
Known or suspected allergy to any component of the study products or similar ingredients in other products
History of significant drug reaction or allergy
Recent history (within 12 months) or presence at screening of contact dermatitis or other dermatological condition
Recent history (within three months of Screening) of a sexually transmitted infection (STI)
Current signs or symptoms of UTI and/or STI at Screening or Baseline
Positive urine leukocyte esterase test (≥ trace)
Biochemical and/or haematological parameters outside the laboratory's normal reference ranges at Screening
Evidence of genital piercing, ulceration, genital dermatoses, tinea cruris or other dermatological condition of the genitalia or upper thighs
Genital pain or discomfort at Screening or Baseline
Any other abnormal finding on physical examination or other medical condition
Clareo Health | SPL7013 Gel - Male Tolerance Study
